Moderna financials
$203.46+3.13%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $145.0M | $389.0M | $678.0M | $1.02B | $142.0M | $108.0M | $966.0M | $1.86B | $241.0M | $167.0M | $2.81B | $1.83B |
| Gross profit | $52.0M | -$566.0M | $226.0M | $809.0M | $23.0M | $18.0M | $227.0M | $1.35B | $126.0M | $71.0M | $1.88B | -$410.0M |
| Gross margin | 35.9% | −145.5% | 33.3% | 79.6% | 16.2% | 16.7% | 23.5% | 72.4% | 52.3% | 42.5% | 67.0% | −22.4% |
| Operating income | -$815.0M | -$1.39B | -$857.0M | -$260.0M | -$907.0M | -$1.05B | -$1.25B | -$70.0M | -$1.36B | -$1.27B | $6.0M | -$2.01B |
| Net income | -$782.0M | -$1.34B | -$826.0M | -$200.0M | -$825.0M | -$971.0M | -$1.12B | $13.0M | -$1.28B | -$1.18B | $217.0M | -$3.63B |
| Net margin | −539.3% | −345.2% | −121.8% | −19.7% | −581.0% | −899.1% | −115.9% | 0.7% | −530.7% | −703.6% | 7.7% | −198.3% |
| Diluted EPS | $-1.97 | $-3.40 | $-2.11 | $-0.51 | $-2.13 | $-2.52 | $-3.02 | $0.03 | $-3.33 | $-3.07 | $0.60 | $-9.53 |
| EBITDA | -$752.0M | -$1.33B | -$790.0M | -$208.0M | -$850.0M | -$1.01B | -$1.19B | -$18.0M | -$1.32B | -$1.23B | $6.0M | -$1.76B |
| Operating cash flow | -$526.0M | -$630.0M | $930.0M | -$847.0M | -$919.0M | -$1.04B | $825.0M | -$1.57B | -$1.27B | -$989.0M | $622.0M | -$1.60B |
| Free cash flow | -$563.0M | -$692.0M | $891.0M | -$880.0M | -$926.0M | -$1.16B | $303.0M | -$1.72B | -$1.46B | -$1.19B | $402.0M | -$1.74B |
| Diluted shares | 398.0M | 395.0M | 392.0M | 390.0M | 388.0M | 386.0M | 371.0M | 399.0M | 384.0M | 382.0M | 361.0M | 381.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.72B | $1.91B | $2.60B | $1.13B | $1.28B | $1.62B |
| Short-term investments | $3.42B | $3.30B | $3.20B | $3.37B | $3.85B | $4.35B |
| Total debt | $597.0M | $603.0M | $610.0M | $26.0M | $32.0M | $35.0M |
| Total assets | $10.96B | $11.49B | $12.34B | $12.13B | $12.01B | $12.70B |
| Total liabilities | $4.20B | $4.08B | $3.69B | $2.81B | $2.61B | $2.64B |
| Shareholders' equity | $6.76B | $7.41B | $8.65B | $9.33B | $9.40B | $10.07B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology